基于PI3K/Akt通路中医药治疗胃癌现状及机制进展研究
Study on the Current Situation and Mechanism of Traditional Chinese Medicine in the Treatment of Gastric Cancer Based on PI3K/Akt Pathway
DOI: 10.12677/acm.2024.1482255, PDF,   
作者: 王圣波:黑龙江中医药大学第一临床医学院,黑龙江 哈尔滨;姜家康*:黑龙江中医药大学附属第一医院,黑龙江 哈尔滨
关键词: 中医药PI3K/Akt通路胃癌调控机制靶向Traditional Chinese Medicine PI3K/Akt Pathway Gastric Cancer Regulatory Mechanism Targeting
摘要: 由于其强度的侵犯和高程度的不稳定特性,胃癌被认为是种复杂且难以处理的情况;它通常会激活多个信号途径以影响许多生物过程。PI3K-Akt蛋白质活性调节器是一个关键的路径系统,对各种病状有着重要关联并且近年来越来受到研究者的关注:因为它们能够刺激大量基因产物的产生而这些物质又可引发一系列生理效应。另一方面,中国传统医学拥有深厚的根基并在长期实践中积累了丰富的经验及独特的能力去协调身体各部分的功能从而预防或减缓疾病的进展——这其中包括对于消化道恶性病变如胃癌的影响上也表现出显著的效果。中医疗法不仅能在一定程度上缓解手术或者化学药物带来的不良后果还能减少一些可能出现的合并症状甚至有抑制瘤体扩散的可能进而提升患者的治愈几率同时也能改善他们的生活品质延长大致的生活年限。因此,我们将对PI3K/Akt信号通路进行全面的系统性分析,以了解近些年来学者们如何运用中医药治疗胃癌。这包括了胃癌细胞的增殖、凋亡、侵袭转移、癌前病变和生长周期等方面。通过研究自噬、耐药性等多个生物学途径,可以明确中医药是如何通过PI3K/Akt信号通路来干预胃癌的过程,从而为胃癌治疗提供新的思路。
Abstract: Because of its intense invasion and high degree of instability, gastric cancer is considered to be complex and difficult to deal with; it usually activates multiple signal pathways to affect many biological processes. PI3K-Akt protein activity regulator is a key pathway system, which has an important relationship with a variety of diseases and has attracted more and more attention of researchers in recent years, because they can stimulate the production of a large number of gene products, and these substances can cause a series of physiological effects. On the other hand, Chinese traditional medicine has a deep foundation and has accumulated rich experience and unique ability in long-term practice to coordinate the functions of various parts of the body so as to prevent or slow down the progress of the disease, including malignant lesions of the digestive tract such as gastric cancer. Traditional Chinese medicine therapy can not only alleviate the adverse consequences caused by surgery or chemical drugs to a certain extent, but also reduce some possible concomitant symptoms and even inhibit the spread of tumors, so as to improve the cure probability of patients, but also improve their quality of life and prolong their general life years. Therefore, we will conduct a comprehensive and systematic analysis of the PI3K/Akt signal pathway in order to understand how scholars use traditional Chinese medicine to treat gastric cancer in recent years. This includes the proliferation, apoptosis, invasion and metastasis, precancerous lesions and growth cycle of gastric cancer cells. Through the study of autophagy, drug resistance and other biological pathways, we can clarify how traditional Chinese medicine interferes with the process of gastric cancer through PI3K/Akt signal pathway, so as to provide new ideas for the treatment of gastric cancer.
文章引用:王圣波, 姜家康. 基于PI3K/Akt通路中医药治疗胃癌现状及机制进展研究[J]. 临床医学进展, 2024, 14(8): 589-597. https://doi.org/10.12677/acm.2024.1482255

参考文献

[1] Lyon, France: International Agency for Research on Cancer.
https://gco.iarc.fr/today/online-analysis-table
[2] Zeng, H., Chen, W., Zheng, R., Zhang, S., Ji, J.S., Zou, X., et al. (2018) Changing Cancer Survival in China during 2003-15: A Pooled Analysis of 17 Population-Based Cancer Registries. The Lancet Global Health, 6, e555-e567. [Google Scholar] [CrossRef] [PubMed]
[3] 马霜, 刘延庆. 中药方剂治疗胃癌的实验研究进展[J]. 健康之友, 2020(6): 266.
[4] 《胃癌中西医结合诊疗指南》标准化项目组. 胃癌中西医结合诊疗指南(2023年) [J]. 中国中西医结合杂志, 2024, 44(3): 261-272.
[5] 马丽娟, 吴欣益, 王锡恩. 中医药靶向PI3K/Akt通路调控胃癌现状及机制进展研究[J]. 中药材, 2024(3): 792-795.
[6] 万金艳, 龙宇, 张羽璐, 等. PI3K/Akt信号通路在糖尿病肾病中的作用及中药干预的研究进展[J]. 中草药, 2021, 52(12): 3705-3716.
[7] Vara, J.Á.F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C. and González-Barón, M. (2004) PI3K-Akt Signalling Pathway and Cancer. Cancer Treatment Reviews, 30, 193-204. [Google Scholar] [CrossRef] [PubMed]
[8] Tewari, D., Patni, P., Bishayee, A., Sah, A.N. and Bishayee, A. (2022) Natural Products Targeting the PI3K-Akt-mTOR Signaling Pathway in Cancer: A Novel Therapeutic Strategy. Seminars in Cancer Biology, 80, 1-17. [Google Scholar] [CrossRef] [PubMed]
[9] Morgos, D., Stefani, C., Miricescu, D., Greabu, M., Stanciu, S., Nica, S., et al. (2024) Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer. International Journal of Molecular Sciences, 25, Article No. 1848. [Google Scholar] [CrossRef] [PubMed]
[10] Li, Q., Li, Z., Luo, T. and Shi, H. (2022) Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK Pathways for Cancer Therapy. Molecular Biomedicine, 3, Article No. 47. [Google Scholar] [CrossRef] [PubMed]
[11] Glaviano, A., Foo, A.S.C., Lam, H.Y., Yap, K.C.H., Jacot, W., Jones, R.H., et al. (2023) PI3K/AKT/mTOR Signaling Transduction Pathway and Targeted Therapies in Cancer. Molecular Cancer, 22, Article No. 138. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, R., Ha, K., Dhandapani, S. and Kim, Y. (2022) Biologically Synthesized Black Ginger-Selenium Nanoparticle Induces Apoptosis and Autophagy of AGS Gastric Cancer Cells by Suppressing the PI3K/Akt/mTOR Signaling Pathway. Journal of Nanobiotechnology, 20, Article No. 441. [Google Scholar] [CrossRef] [PubMed]
[13] Koh, V., Chakrabarti, J., Torvund, M., Steele, N., Hawkins, J.A., Ito, Y., et al. (2021) Hedgehog Transcriptional Effector GLI Mediates mTOR-Induced PD-L1 Expression in Gastric Cancer Organoids. Cancer Letters, 518, 59-71. [Google Scholar] [CrossRef] [PubMed]
[14] Han, S., Lee, J., Woo, J., Jung, G., Jung, S., Han, E., et al. (2022) Myricetin Induces Apoptosis and Autophagy in Human Gastric Cancer Cells through Inhibition of the PI3K/Akt/mTOR Pathway. Heliyon, 8, e09309. [Google Scholar] [CrossRef] [PubMed]
[15] Yu, L., Wei, J. and Liu, P. (2022) Attacking the PI3K/Akt/mTOR Signaling Pathway for Targeted Therapeutic Treatment in Human Cancer. Seminars in Cancer Biology, 85, 69-94. [Google Scholar] [CrossRef] [PubMed]
[16] Stanland, L.J., Ang, H.X., Hoj, J.P., Chu, Y., Tan, P., Wood, K.C., et al. (2023) CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer. Molecular Cancer Research, 21, 1148-1162. [Google Scholar] [CrossRef] [PubMed]
[17] Iranpour, M., Nourian, M., Saffari, S., Samizadeh, E., Mirghafori, M., Iravani, S., et al. (2019) PIK3CA Mutation Analysis in Iranian Patients with Gastric Cancer. Iranian Biomedical Journal, 23, 87-91. [Google Scholar] [CrossRef
[18] Matsuoka, T. and Yashiro, M. (2014) The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma. Cancers, 6, 1441-1463. [Google Scholar] [CrossRef] [PubMed]
[19] Wang, C., Yang, Z., Xu, E., Shen, X., Wang, X., Li, Z., et al. (2021) Apolipoprotein C‐II Induces EMT to Promote Gastric Cancer Peritoneal Metastasis via PI3K/AKT/mTOR Pathway. Clinical and Translational Medicine, 11, e522. [Google Scholar] [CrossRef] [PubMed]
[20] 汪显超, 李娜, 黄静, 等. 胃癌患者中医证型与发病节气的相关性研究[J]. 世界科学技术-中医药现代化, 2023, 25(10): 3384-3393.
[21] 桑天庆, 郑玉玲. 基于培土固本思想以和法辨治胃癌经验[J]. 中华中医药杂志, 2023, 38(11): 5315-5318.
[22] Wang, Y., Guan, W., Zhou, Y., Zhang, X. and Zhao, H. (2023) Red Ginseng Polysaccharide Promotes Ferroptosis in Gastric Cancer Cells by Inhibiting PI3K/Akt Pathway through Down-Regulation of AQP3. Cancer Biology & Therapy, 25, Article ID: 2284849. [Google Scholar] [CrossRef] [PubMed]
[23] 孙逸飞, 李迪诺, 王玉彬. 姜黄素通过下调PI3K/Akt/mTOR信号通路蛋白表达对胃癌MGC-803细胞增殖和侵袭的抑制作用[J]. 吉林大学学报(医学版), 2023, 49(2): 332-340.
[24] 龚红霞, 李婷婷, 苏韫, 等. 归芪白术方含药血清通过PI3K/AKT信号通路对共培养的胃癌MKN-45细胞凋亡的影响[J]. 时珍国医国药, 2021, 32(12): 2890-2893.
[25] 窦建卫, 杨艺, 杨小蒨, 等. 和胃降逆胶囊通过PI3K/AKT信号通路调控人胃癌AGS细胞增殖与凋亡机制研究[J]. 山东中医药大学学报, 2022, 46(1): 101-107.
[26] 黄勇, 张晗, 龚红霞, 等. 基于PI3K/Akt/caspase-9信号通路研究归芪白术方联合奥沙利铂对胃癌荷瘤小鼠胃癌细胞凋亡的影响[J]. 中国药理学通报, 2023, 39(9): 1781-1786.
[27] 谭鹏, 张云封, 王龙燕, 等. 一种新型查耳酮衍生物C13通过ErbB4/PI3K/AKT信号通路抑制人胃癌细胞的生长[J]. 药学学报, 2024, 59(4): 957-964.
[28] 葛亚楠, 陈建军, 吴腾飞, 等. 尪五味子乙素通过PI3K/Akt信号通路调控内质网应激促进胃癌细胞凋亡[J]. 解剖科学进展, 2022, 28(6): 755-758.
[29] 王蒙. 通关藤口服液及其有效成分山柰酚通过PI3K/AKT通路抑制胃癌细胞增殖的分子机制研究[D]: [硕士学位论文]. 兰州: 甘肃中医药大学, 2023.
[30] 李乡南, 苗兰英, 孙宏伟, 等. 基于转录组学探讨四君子汤增强顺铂抗胃癌作用的机制[J]. 中华中医药杂志, 2023, 38(6): 2856-2861.
[31] 姜金玲, 候骄洋, 姚国栋. 基于网络药理学的黄瑞香抗胃癌作用机制探讨及实验验证[J]. 药物评价研究, 2023, 46(1): 24-36.
[32] 牟睿宇, 李小江, 牛潇菲, 等. 基于VEGF/PI3K/AKT通路探讨消岩汤联合阿帕替尼抑制胃癌MGC-803细胞增殖的作用机制研究[J]. 天津中医药, 2024, 41(3): 354-359.
[33] 何锋, 狐鸣, 冯世林, 等. 银杏内酯B通过阻抑PI3K/Akt/mTOR信号通路抑制胃癌HGC-27细胞的恶性生物学行为[J]. 中国肿瘤生物治疗杂志, 2023, 30(10): 874-880.
[34] 张欣, 霍浩然, 秦瑞峰, 等. 紫草素抑制PI_3K/Akt/mTOR通路逆转人胃癌细胞奥沙利铂耐药[J]. 医学研究杂志, 2023, 52(6): 127-131+35.
[35] 陈丹媛, 罗敏, 高卓维, 等. 基于网络药理学及分子对接探讨龙葵-肿节风药对治疗胃癌的作用机制[J]. 现代消化及介入诊疗, 2023, 28(9): 1117-1124.
[36] 景燕燕. 基于HIF-1α介导的PI3K/AKT信号通路研究蜥蜴胃康方对胃癌肝转移的干预作用及机制[D]: [硕士学位论文]. 银川: 宁夏医科大学, 2022.
[37] 乔丹, 张晟郡, 王时玉, 等. 黄芩素介导FAK蛋白调控PI3K/Akt信号通路抑制胃癌HGC-27细胞增殖和迁移[J]. 中国实验方剂学杂志, 2022, 28(7): 73-80.
[38] 王艳, 张金辉, 赵永辰, 等. 红杉黄酮通过下调PI3K/AKT信号通路抑制胃癌细胞增殖侵袭等干细胞特性[J]. 中国临床药理学与治疗学, 2023, 28(5): 508-513.
[39] 朱玲琴. SKAP1通过JAK1/PI3K/AKT信号轴调控胃癌增殖、侵袭和迁移的研究[D]: [硕士学位论文]. 南昌: 南昌大学, 2023.
[40] 陈光. 蟾毒灵靶向BFAR调控PI3K/AKT/mTOR信号通路抑制胃癌发生和进展[D]: [硕士学位论文]. 青岛: 青岛大学, 2023.
[41] 孙阳, 孙悦, 顾媛媛, 等. mTOR信号通路在细胞自噬和凋亡调节中的作用[J]. 中国医学装备, 2021, 18(1): 162-166.
[42] 易志荣, 林倚莉, 王煜姣, 等. 莪连颗粒对胃癌大鼠胃组织自噬及PI3K/Akt/mTOR信号通路的影响[J]. 中国实验方剂学杂志, 2021, 27(22): 84-91.
[43] 张欣, 霍浩然, 张振翼, 等. 紫草素调控PI3K/Akt/mTOR通路对人胃癌MGC803细胞自噬和凋亡的影响[J]. 中国现代普通外科进展, 2023, 26(7): 511-515.